|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 38/10 | (2013.01) | ||
| A61K 38/10 | (2006.01) | ||
| A61K 38/39 | (2013.01) | ||
| A61K 38/39 | (2006.01) | ||
| A61P 7/10 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61K 38/00 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3522906 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17859077.4 |
| Date of filing the European patent application | 2017-10-04 | |
| (97) | Date of publication of the European application | 2019-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/055055 |
| Date | 2017-10-04 |
| (87) | Number | WO 2018/067646 |
| Date | 2018-04-12 |
| (30) | Number | Date | Country code |
| 201662403786 P | 2016-10-04 | US |
| (72) |
PANDEY, Niranjan, B. , US
MIRANDO, Adam , US
POPEL, Aleksander, S. , US
GREEN, Jordan, J. , US
|
| (73) |
Asclepix Therapeutics, Inc. ,
301 West 29th Street, Suite 2004, Baltimore, MD 21211,
US
The Johns Hopkins University , 3400 North Charles Street, Baltimore, MD 21218, US |
| (54) | COMPOUNDS AND METHODS FOR ACTIVATING TIE2 SIGNALING |
| COMPOUNDS AND METHODS FOR ACTIVATING TIE2 SIGNALING |